Celldex Therapeutics Inc
For the period ended Dec 31, 2023. Filed Feb 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 26, 2024
CLDX$31.24+4.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
As of December 31, 2023, our significant leased properties are described below.
| · · · · · · | |||
|---|---|---|---|
| | Approximate | | |
| Property Location | Square Feet | Use | Lease Expiration Date |
| Hampton, New Jersey | 33,400 | Headquarters, Office and Laboratory | July 2025(1) |
| Fall River, Massachusetts | 33,900 | Manufacturing, Office and Laboratory | July 2025(2) |
| New Haven, Connecticut | 17,700 | Office and Laboratory | April 2025 |
| (1) | Lease includes one renewal option of two years followed by one renewal option of three years. |
| (2) | Lease includes one renewal option of two years followed by one renewal option of three years. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.